University of Cambridge > > mb915's list > Targeting RNA biology in colorectal cancer

Targeting RNA biology in colorectal cancer

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Michael Boemo.

Advanced colorectal cancers are treated with first line chemotherapy combinations that have broad molecular effects within tumour and non-tumour cells. Despite a huge reliance on these therapies for colorectal and other cancers we do not fully understand how they work at the molecular level. Recent advances have highlighted a forgotten role for these compounds in RNA biology that needs revisiting. Consistent with RNA being an actionable vulnerability in colorectal cancer I have demonstrated multiple means to target RNA in preclinical models of the disease. Building on this, my group have developed innovative methods to define how current chemotherapies affect RNA biology in exquisite detail. With this knowledge we hope to identify what determines drug response in disease and design replacement targeted therapies drawing on advances in RNA -based pharmaceuticals.

This talk is part of the mb915's list series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity